ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Factor VIII Deficiency Treatment Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-24V2864
Home | Market Reports | Health| Health Conditions| Cancer
Global Factor VIII Deficiency Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Factor VIII Deficiency Treatment Market Research Report 2025

Code: QYRE-Auto-24V2864
Report
September 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Takeda
Bayer HealthCare
CSL Limited
Grifols S A
F.Hoffmann-La Roche
Kedrion S p A
Octapharma AG
Biogen Idec
BioMarin Pharmaceutical
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure
Amarna Therapeutics
Dimension Therapeutics
Novo Nordisk

Factor VIII Deficiency Treatment Market

The global market for Factor VIII Deficiency Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream in an inactive form, and binds to another molecule called von Willebrand factor, until a damage to blood vessels occur. In response to injury, coagulation factor VIII gets activated and separates from von Willebrand factor.
The global hemophilia A drugs market segment accounted for the majority market share and will continue to dominate the factor 8 deficiency treatment market for the next few years. Some of the major factors responsible for the market segment"s growth is the growing incidence of hemophilia A, the development of novel drugs with extended action, and the increased adoption of prophylactic treatment. Additionally, growing demand for novel recombinant extended half-life products, the emergence of monoclonal antibodies and gene therapy products, and launch of plasma-derived products for recombinant factor VIII at low costs, will also further drive the growth of the factor VIII deficiency treatment market.
This report aims to provide a comprehensive presentation of the global market for Factor VIII Deficiency Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor VIII Deficiency Treatment.
The Factor VIII Deficiency Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Factor VIII Deficiency Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Factor VIII Deficiency Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Factor VIII Deficiency Treatment Market Report

Report Metric Details
Report Name Factor VIII Deficiency Treatment Market
Segment by Type
  • Hemophilia A Drugs
  • Hemophilia A Inhibitors Treatment
  • Von Willebrand Disease Treatment
Segment by Application
  • Hospitals
  • Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Takeda, Bayer HealthCare, CSL, Grifols, Novo Nordisk, F. Hoffmann-La Roche, Kedrion, Octapharma, Biogen Idec, BioMarin Pharmaceutical, Sangamo Therapeutics, Spark Therapeutics, Swedish Orphan Biovitrum, Uniqure NV, Amarna Therapeutics, Dimension Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Factor VIII Deficiency Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Factor VIII Deficiency Treatment Market report?

Ans: The main players in the Factor VIII Deficiency Treatment Market are Pfizer, Takeda, Bayer HealthCare, CSL, Grifols, Novo Nordisk, F. Hoffmann-La Roche, Kedrion, Octapharma, Biogen Idec, BioMarin Pharmaceutical, Sangamo Therapeutics, Spark Therapeutics, Swedish Orphan Biovitrum, Uniqure NV, Amarna Therapeutics, Dimension Therapeutics

What are the Application segmentation covered in the Factor VIII Deficiency Treatment Market report?

Ans: The Applications covered in the Factor VIII Deficiency Treatment Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Factor VIII Deficiency Treatment Market report?

Ans: The Types covered in the Factor VIII Deficiency Treatment Market report are Hemophilia A Drugs, Hemophilia A Inhibitors Treatment, Von Willebrand Disease Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hemophilia A Drugs
1.2.3 Hemophilia A Inhibitors Treatment
1.2.4 Von Willebrand Disease Treatment
1.3 Market by Application
1.3.1 Global Factor VIII Deficiency Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Factor VIII Deficiency Treatment Market Perspective (2020-2031)
2.2 Global Factor VIII Deficiency Treatment Growth Trends by Region
2.2.1 Global Factor VIII Deficiency Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Factor VIII Deficiency Treatment Historic Market Size by Region (2020-2025)
2.2.3 Factor VIII Deficiency Treatment Forecasted Market Size by Region (2026-2031)
2.3 Factor VIII Deficiency Treatment Market Dynamics
2.3.1 Factor VIII Deficiency Treatment Industry Trends
2.3.2 Factor VIII Deficiency Treatment Market Drivers
2.3.3 Factor VIII Deficiency Treatment Market Challenges
2.3.4 Factor VIII Deficiency Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Factor VIII Deficiency Treatment Players by Revenue
3.1.1 Global Top Factor VIII Deficiency Treatment Players by Revenue (2020-2025)
3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Factor VIII Deficiency Treatment Revenue
3.4 Global Factor VIII Deficiency Treatment Market Concentration Ratio
3.4.1 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Factor VIII Deficiency Treatment Revenue in 2024
3.5 Global Key Players of Factor VIII Deficiency Treatment Head office and Area Served
3.6 Global Key Players of Factor VIII Deficiency Treatment, Product and Application
3.7 Global Key Players of Factor VIII Deficiency Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Factor VIII Deficiency Treatment Breakdown Data by Type
4.1 Global Factor VIII Deficiency Treatment Historic Market Size by Type (2020-2025)
4.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2026-2031)
5 Factor VIII Deficiency Treatment Breakdown Data by Application
5.1 Global Factor VIII Deficiency Treatment Historic Market Size by Application (2020-2025)
5.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Factor VIII Deficiency Treatment Market Size (2020-2031)
6.2 North America Factor VIII Deficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Factor VIII Deficiency Treatment Market Size by Country (2020-2025)
6.4 North America Factor VIII Deficiency Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Factor VIII Deficiency Treatment Market Size (2020-2031)
7.2 Europe Factor VIII Deficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Factor VIII Deficiency Treatment Market Size by Country (2020-2025)
7.4 Europe Factor VIII Deficiency Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size (2020-2031)
8.2 Asia-Pacific Factor VIII Deficiency Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Factor VIII Deficiency Treatment Market Size (2020-2031)
9.2 Latin America Factor VIII Deficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Factor VIII Deficiency Treatment Market Size by Country (2020-2025)
9.4 Latin America Factor VIII Deficiency Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size (2020-2031)
10.2 Middle East & Africa Factor VIII Deficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Factor VIII Deficiency Treatment Introduction
11.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Factor VIII Deficiency Treatment Introduction
11.2.4 Takeda Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.2.5 Takeda Recent Development
11.3 Bayer HealthCare
11.3.1 Bayer HealthCare Company Details
11.3.2 Bayer HealthCare Business Overview
11.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Introduction
11.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.3.5 Bayer HealthCare Recent Development
11.4 CSL
11.4.1 CSL Company Details
11.4.2 CSL Business Overview
11.4.3 CSL Factor VIII Deficiency Treatment Introduction
11.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.4.5 CSL Recent Development
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Grifols Business Overview
11.5.3 Grifols Factor VIII Deficiency Treatment Introduction
11.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.5.5 Grifols Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Factor VIII Deficiency Treatment Introduction
11.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.6.5 Novo Nordisk Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Kedrion
11.8.1 Kedrion Company Details
11.8.2 Kedrion Business Overview
11.8.3 Kedrion Factor VIII Deficiency Treatment Introduction
11.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.8.5 Kedrion Recent Development
11.9 Octapharma
11.9.1 Octapharma Company Details
11.9.2 Octapharma Business Overview
11.9.3 Octapharma Factor VIII Deficiency Treatment Introduction
11.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.9.5 Octapharma Recent Development
11.10 Biogen Idec
11.10.1 Biogen Idec Company Details
11.10.2 Biogen Idec Business Overview
11.10.3 Biogen Idec Factor VIII Deficiency Treatment Introduction
11.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.10.5 Biogen Idec Recent Development
11.11 BioMarin Pharmaceutical
11.11.1 BioMarin Pharmaceutical Company Details
11.11.2 BioMarin Pharmaceutical Business Overview
11.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Introduction
11.11.4 BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.11.5 BioMarin Pharmaceutical Recent Development
11.12 Sangamo Therapeutics
11.12.1 Sangamo Therapeutics Company Details
11.12.2 Sangamo Therapeutics Business Overview
11.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Introduction
11.12.4 Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.12.5 Sangamo Therapeutics Recent Development
11.13 Spark Therapeutics
11.13.1 Spark Therapeutics Company Details
11.13.2 Spark Therapeutics Business Overview
11.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Introduction
11.13.4 Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.13.5 Spark Therapeutics Recent Development
11.14 Swedish Orphan Biovitrum
11.14.1 Swedish Orphan Biovitrum Company Details
11.14.2 Swedish Orphan Biovitrum Business Overview
11.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Introduction
11.14.4 Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.14.5 Swedish Orphan Biovitrum Recent Development
11.15 Uniqure NV
11.15.1 Uniqure NV Company Details
11.15.2 Uniqure NV Business Overview
11.15.3 Uniqure NV Factor VIII Deficiency Treatment Introduction
11.15.4 Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.15.5 Uniqure NV Recent Development
11.16 Amarna Therapeutics
11.16.1 Amarna Therapeutics Company Details
11.16.2 Amarna Therapeutics Business Overview
11.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Introduction
11.16.4 Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.16.5 Amarna Therapeutics Recent Development
11.17 Dimension Therapeutics
11.17.1 Dimension Therapeutics Company Details
11.17.2 Dimension Therapeutics Business Overview
11.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Introduction
11.17.4 Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2020-2025)
11.17.5 Dimension Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Takeda
Bayer HealthCare
CSL Limited
Grifols S A
F.Hoffmann-La Roche
Kedrion S p A
Octapharma AG
Biogen Idec
BioMarin Pharmaceutical
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure
Amarna Therapeutics
Dimension Therapeutics
Novo Nordisk
List of Tables
 Table 1. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Hemophilia A Drugs
 Table 3. Key Players of Hemophilia A Inhibitors Treatment
 Table 4. Key Players of Von Willebrand Disease Treatment
 Table 5. Global Factor VIII Deficiency Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Factor VIII Deficiency Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Factor VIII Deficiency Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Factor VIII Deficiency Treatment Market Share by Region (2020-2025)
 Table 9. Global Factor VIII Deficiency Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Factor VIII Deficiency Treatment Market Share by Region (2026-2031)
 Table 11. Factor VIII Deficiency Treatment Market Trends
 Table 12. Factor VIII Deficiency Treatment Market Drivers
 Table 13. Factor VIII Deficiency Treatment Market Challenges
 Table 14. Factor VIII Deficiency Treatment Market Restraints
 Table 15. Global Factor VIII Deficiency Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Factor VIII Deficiency Treatment Market Share by Players (2020-2025)
 Table 17. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2024)
 Table 18. Ranking of Global Top Factor VIII Deficiency Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Factor VIII Deficiency Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Factor VIII Deficiency Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Factor VIII Deficiency Treatment, Product and Application
 Table 22. Global Key Players of Factor VIII Deficiency Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Factor VIII Deficiency Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global Factor VIII Deficiency Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Factor VIII Deficiency Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Factor VIII Deficiency Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Factor VIII Deficiency Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Factor VIII Deficiency Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Factor VIII Deficiency Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Factor VIII Deficiency Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Factor VIII Deficiency Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Factor VIII Deficiency Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Factor VIII Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Pfizer Company Details
 Table 48. Pfizer Business Overview
 Table 49. Pfizer Factor VIII Deficiency Treatment Product
 Table 50. Pfizer Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 51. Pfizer Recent Development
 Table 52. Takeda Company Details
 Table 53. Takeda Business Overview
 Table 54. Takeda Factor VIII Deficiency Treatment Product
 Table 55. Takeda Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 56. Takeda Recent Development
 Table 57. Bayer HealthCare Company Details
 Table 58. Bayer HealthCare Business Overview
 Table 59. Bayer HealthCare Factor VIII Deficiency Treatment Product
 Table 60. Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 61. Bayer HealthCare Recent Development
 Table 62. CSL Company Details
 Table 63. CSL Business Overview
 Table 64. CSL Factor VIII Deficiency Treatment Product
 Table 65. CSL Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 66. CSL Recent Development
 Table 67. Grifols Company Details
 Table 68. Grifols Business Overview
 Table 69. Grifols Factor VIII Deficiency Treatment Product
 Table 70. Grifols Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 71. Grifols Recent Development
 Table 72. Novo Nordisk Company Details
 Table 73. Novo Nordisk Business Overview
 Table 74. Novo Nordisk Factor VIII Deficiency Treatment Product
 Table 75. Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 76. Novo Nordisk Recent Development
 Table 77. F. Hoffmann-La Roche Company Details
 Table 78. F. Hoffmann-La Roche Business Overview
 Table 79. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product
 Table 80. F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 81. F. Hoffmann-La Roche Recent Development
 Table 82. Kedrion Company Details
 Table 83. Kedrion Business Overview
 Table 84. Kedrion Factor VIII Deficiency Treatment Product
 Table 85. Kedrion Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 86. Kedrion Recent Development
 Table 87. Octapharma Company Details
 Table 88. Octapharma Business Overview
 Table 89. Octapharma Factor VIII Deficiency Treatment Product
 Table 90. Octapharma Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 91. Octapharma Recent Development
 Table 92. Biogen Idec Company Details
 Table 93. Biogen Idec Business Overview
 Table 94. Biogen Idec Factor VIII Deficiency Treatment Product
 Table 95. Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 96. Biogen Idec Recent Development
 Table 97. BioMarin Pharmaceutical Company Details
 Table 98. BioMarin Pharmaceutical Business Overview
 Table 99. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product
 Table 100. BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 101. BioMarin Pharmaceutical Recent Development
 Table 102. Sangamo Therapeutics Company Details
 Table 103. Sangamo Therapeutics Business Overview
 Table 104. Sangamo Therapeutics Factor VIII Deficiency Treatment Product
 Table 105. Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 106. Sangamo Therapeutics Recent Development
 Table 107. Spark Therapeutics Company Details
 Table 108. Spark Therapeutics Business Overview
 Table 109. Spark Therapeutics Factor VIII Deficiency Treatment Product
 Table 110. Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 111. Spark Therapeutics Recent Development
 Table 112. Swedish Orphan Biovitrum Company Details
 Table 113. Swedish Orphan Biovitrum Business Overview
 Table 114. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product
 Table 115. Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 116. Swedish Orphan Biovitrum Recent Development
 Table 117. Uniqure NV Company Details
 Table 118. Uniqure NV Business Overview
 Table 119. Uniqure NV Factor VIII Deficiency Treatment Product
 Table 120. Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 121. Uniqure NV Recent Development
 Table 122. Amarna Therapeutics Company Details
 Table 123. Amarna Therapeutics Business Overview
 Table 124. Amarna Therapeutics Factor VIII Deficiency Treatment Product
 Table 125. Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 126. Amarna Therapeutics Recent Development
 Table 127. Dimension Therapeutics Company Details
 Table 128. Dimension Therapeutics Business Overview
 Table 129. Dimension Therapeutics Factor VIII Deficiency Treatment Product
 Table 130. Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2020-2025) & (US$ Million)
 Table 131. Dimension Therapeutics Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Factor VIII Deficiency Treatment Picture
 Figure 2. Global Factor VIII Deficiency Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Factor VIII Deficiency Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Hemophilia A Drugs Features
 Figure 5. Hemophilia A Inhibitors Treatment Features
 Figure 6. Von Willebrand Disease Treatment Features
 Figure 7. Global Factor VIII Deficiency Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Factor VIII Deficiency Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Other Case Studies
 Figure 12. Factor VIII Deficiency Treatment Report Years Considered
 Figure 13. Global Factor VIII Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Factor VIII Deficiency Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Factor VIII Deficiency Treatment Market Share by Region: 2024 VS 2031
 Figure 16. Global Factor VIII Deficiency Treatment Market Share by Players in 2024
 Figure 17. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Factor VIII Deficiency Treatment Revenue in 2024
 Figure 19. North America Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Factor VIII Deficiency Treatment Market Share by Country (2020-2031)
 Figure 21. United States Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Factor VIII Deficiency Treatment Market Share by Country (2020-2031)
 Figure 25. Germany Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Factor VIII Deficiency Treatment Market Share by Region (2020-2031)
 Figure 33. China Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Factor VIII Deficiency Treatment Market Share by Country (2020-2031)
 Figure 41. Mexico Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Factor VIII Deficiency Treatment Market Share by Country (2020-2031)
 Figure 45. Turkey Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Factor VIII Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 49. Takeda Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 50. Bayer HealthCare Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 51. CSL Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 52. Grifols Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 53. Novo Nordisk Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 55. Kedrion Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 56. Octapharma Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 57. Biogen Idec Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 58. BioMarin Pharmaceutical Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 59. Sangamo Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 60. Spark Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 61. Swedish Orphan Biovitrum Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 62. Uniqure NV Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 63. Amarna Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 64. Dimension Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Human Coagulation Factor VIII Market Research Report 2020
Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma derived Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Antihemophilic Globulin Market Research Report 2024
Global Hemophilia AAV Gene Therapy Market Research Report 2024
Rare Hemophilia Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antihemophilic Factor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemophilia Treatment Medications Market Research Report 2024
Global Medication for Hemophilia Market Research Report 2024
Global Hemophilia monoclonal antibody Market Research Report 2024
Hemophilia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factor Concentrate Market Research Report 2024
Global Hemophilia Medication Market Research Report 2024
Global Factor IX Deficiency Treatment Market Research Report 2024
Owren s Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Factor VIII Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antihemophilic Factor von Willebrand Factor Complex Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions